ArticleTherapeutic advances in respiratory disease2016

Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection.

Fumitaka Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.